NCT02673866View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

February 28, 2017

Conditions

Neuropathic PainDiabetes

Interventions

DRUG

DS-1971a

DRUG

placebo

DRUG

pregabalin

pregabalin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY